Back to Journals » International Journal of Nanomedicine » Volume 14

Hexagonal Boron Nitrides (White Graphene): A Promising Method for Cancer Drug Delivery

Authors Sharker SM

Received 6 October 2019

Accepted for publication 10 December 2019

Published 19 December 2019 Volume 2019:14 Pages 9983—9993

DOI https://doi.org/10.2147/IJN.S205095

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Thomas Webster


Shazid Md Sharker

Department of Pharmaceutical Sciences, North South University, Dhaka 1229, Bangladesh

Correspondence: Shazid Md Sharker
Department of Pharmaceutical Sciences, North South University, Plot # 15, Block # B, Bashundhara R/A, Dhaka 1229, Bangladesh
Tel +880-2-55668200, Ext: 6281
Email shazid.sharker@northsouth.edu

Abstract: Advances in low-dimensions nanomaterials drug-carrier have rapidly translated into clinical practice. Interestingly, the two-dimensional (2D) nanomaterials of hexagonal boron nitride (h-BN), so-called “white graphite” are relatively less explored compared to the post popular 2D graphene oxide (GO). However, the unique properties of h-BN nanomaterials make them well suited for the delivery of chemotherapeutic in cancer treatment. Recent studies have shown that the h-BN is a potential candidate in biomedical sciences, both as nanocarriers and nano-transducers. In this review, we discuss the various physicochemical properties and important concepts involved in h-BN nanosheets as anticancer drug carriers.

Keywords: h-BN, functionalization, biomedical potentiality, biomaterials, anticancer drug delivery

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]